ANDA 84107, held by Mutual Pharm. Hydralazine Hydrochloride.
As of Nov 16, 2026, ANDA 84107 (Hydralazine Hydrochloride), held by Mutual Pharm, was first approved by FDA on Nov 8, 1974, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 8, 1974 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydralazine Hydrochloride50MG ยท tablet;oral | Hydralazine Hydrochloride | Discontinued |
| Dec 1, 1998 | Supplement 70Manufacturing | Approved | None posted |
| Dec 23, 1994 | Supplement 69Manufacturing | Approved | None posted |
| Oct 11, 1994 | Supplement 68Manufacturing | Approved | None posted |
| Apr 3, 1992 | Supplement 65Manufacturing | Approved | None posted |
| Apr 3, 1992 | Supplement 67Manufacturing | Approved | None posted |
| Apr 22, 1988 | Supplement 63Manufacturing | Approved | None posted |
| Mar 25, 1987 | Supplement 60Manufacturing | Approved | None posted |
| Nov 12, 1985 | Supplement 55Manufacturing | Approved | None posted |
| Nov 12, 1985 | Supplement 56Manufacturing | Approved | None posted |
| Nov 8, 1974 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters